LEADER 01418nam  2200397Ia 450 
001 9910698947903321
005 20090707161109.0
035   $a(CKB)5470000002398397
035   $a(OCoLC)422767412
035   $a(EXLCZ)995470000002398397
100   $a20090707d1997      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eS6 preclinical safety evaluation of biotechnology-derived pharmaceuticals
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research :$cCenter for Biologics Evaluation and Research,$d[1997]
215   $ai, 11 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on July 7, 2009).
300   $a"ICH".
300   $a"July 1997".
517   $aGuidance for industry 
606   $aDrugs$xTesting
606   $aBiopharmaceutics
615  0$aDrugs$xTesting.
615  0$aBiopharmaceutics.
712 02$aCenter for Drug Evaluation and Research (U.S.)
712 02$aCenter for Biologics Evaluation and Research (U.S.)
712 12$aInternational Conference on Harmonisation.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698947903321
996   $aGuidance for industry$93434577
997   $aUNINA